 TEL AVIV, Israel, Oct. 14, 2021 GLOBE NEWSWIRE -- PainReform Ltd. Nasdaq: PRFX PainReform or the Company, a clinical-stage specialty pharmaceutical company focused on the reformulation of established therapeutics, today announced that Ilan Hadar, Chief Executive Officer of PainReform, will present at the Dawson James Securities Small Cap Growth Conference being held on October 21, 2021 at the Wyndham Grand Hotel in Jupiter, Florida. 